This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/520362-south-korea-suspends-astrazeneca-covid-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
Version 0 | Version 1 |
---|---|
South Korea suspends use of AstraZeneca Covid-19 vaccine in people under 60 ahead of EU blood clot review results | South Korea suspends use of AstraZeneca Covid-19 vaccine in people under 60 ahead of EU blood clot review results |
(5 months later) | |
Health chiefs in South Korea have announced the temporary suspension of the AstraZeneca Covid-19 vaccine for the under-60s, pending the results of a review by the EU’s drug regulator into the jab’s safety. | Health chiefs in South Korea have announced the temporary suspension of the AstraZeneca Covid-19 vaccine for the under-60s, pending the results of a review by the EU’s drug regulator into the jab’s safety. |
Vaccinations for pupils in special education, teachers and daycare center nurses, which were to go ahead from April 8, will also be postponed. | Vaccinations for pupils in special education, teachers and daycare center nurses, which were to go ahead from April 8, will also be postponed. |
In South Korea, a female medical worker in her 20s suffered blood clots in her legs and lungs after receiving the AstraZeneca vaccine. | In South Korea, a female medical worker in her 20s suffered blood clots in her legs and lungs after receiving the AstraZeneca vaccine. |
On Wednesday the head of the country’s disease control agency, Jeong Eun-kyeong, described the move as a “pre-emptive measure” to keep the public safe in light of the jab’s potential link to rare blood clotting. | On Wednesday the head of the country’s disease control agency, Jeong Eun-kyeong, described the move as a “pre-emptive measure” to keep the public safe in light of the jab’s potential link to rare blood clotting. |
The country’s food and drug safety ministry has also approved the Covid-19 vaccine made by Johnson & Johnson. | The country’s food and drug safety ministry has also approved the Covid-19 vaccine made by Johnson & Johnson. |
It is the third jab approved for use after those made by AstraZeneca and Pfizer. | It is the third jab approved for use after those made by AstraZeneca and Pfizer. |
South Korean health chiefs have said they will respond to the European Medical Agency’s (EMA) review into the safety of the AstraZeneca jab, the results of which are set to be made public today. | South Korean health chiefs have said they will respond to the European Medical Agency’s (EMA) review into the safety of the AstraZeneca jab, the results of which are set to be made public today. |
A number of countries in Europe and elsewhere halted their rollouts of the vaccine after cases of rare blood clotting were reported in people who had received it. | A number of countries in Europe and elsewhere halted their rollouts of the vaccine after cases of rare blood clotting were reported in people who had received it. |
Like this story? Share it with a friend! | Like this story? Share it with a friend! |
Dear readers and commenters, | |
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
Sorry for the inconvenience, and looking forward to your future comments, | |
RT Team. |